A three-dimensional human neural cell culture model of Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature

• Publication date

  2014-10-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature13800PMID 25307057PMCID PMC4366007
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species

  2014cited by this paper
• Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors

  2014cited by this paper
• The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.

  2014cited by this paper
• Bioengineered functional brain-like cortical tissue

  2014cited by this paper
• A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Aβ, and Frank Neuronal Loss

  2013cited by this paper
• Cerebral organoids model human brain development and microcephaly

  2013cited by this paper
• Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

  2013cited by this paper
• 3D Differentiation of Neural Stem Cells in Macroporous Photopolymerizable Hydrogel Scaffolds

  2012cited by this paper
• iPSCs to the rescue in Alzheimer's research.

  2012cited by this paper
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells

  2012cited by this paper
• Cultivation of human neural progenitor cells in a 3-dimensional self-assembling peptide hydrogel.

  2012cited by this paper
• Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

  2012cited by this paper
• Modeling familial Alzheimer's disease with induced pluripotent stem cells.

  2011cited by this paper
• GSK-3α/β kinases and amyloid production in vivo

  2011cited by this paper
• Quantitative and kinetic profile of Wnt/β-catenin signaling components during human neural progenitor cell differentiation

  2011cited by this paper
• Selecting a mouse model of Alzheimer's disease.

  2010cited by this paper
• Human Stem Cell-Derived Neurons: A System to Study Human Tau Function and Dysfunction

  2010cited by this paper
• Autophagy in disease and clinical applications

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia

  2009cited by this paper
• Protection of neurons derived from human neural progenitor cells by veratridine

  2009cited by this paper
• Differential development of neuronal physiological responsiveness in two human neural stem cell lines

  2007cited by this paper
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.

  2004cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003cited by this paper
• GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

  2003cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Neuropsychopharmacology : The Fifth Generation of Progress

  2002cited by this paper
• The role of tau in Alzheimer's disease.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis.

  2000cited by this paper
• Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

  1990cited by this paper
• Use of excitatory amino acids to make axon-sparing lesions of hypothalamus.

  1983cited by this paper
• [25] Use of excitatory amino acids to make axon-sparing lesions of hypothalamus

  1983cited by this paper

• Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition

  2026cites this paper
• Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer’s Disease

  2026cites this paper
• Brain organoids as precision models for neurodegenerative diseases: from disease modeling to drug discovery.

  2026cites this paper
• Multi-omic analysis of guided and unguided forebrain organoids reveals differences in cellular composition and metabolic profiles.

  2026cites this paper
• Immunity in Alzheimer's disease: From mechanisms to therapies.

  2026cites this paper
• Glial and Neuronal Alzheimer's Disease-Related Alterations Reproduced in Human Induced Pluripotent Stem Cells With Presenilin-1 Mutation

  2026cites this paper
• Current and Future Applications of Three-Dimensional Brain and Cardiac Organoids in Translational Medicine: From Disease Modeling to Drug Discovery

  2026cites this paper
• Harnessing induced pluripotent stem cells and organoids for disease modeling and precision medicine.

  2026cites this paper
• Three-dimensional human brain organoids: A next-generation model to decode Alzheimer’s disease

  2026cites this paper
• Therapeutic Options for Alzheimer’s Disease and Aging-Associated Cognitive Decline: State of the Art in the ACH2.0 Paradigm

  2026cites this paper
• Human in vitro and rodent in vivo models highlight progressive mitochondrial dysfunction as a starting point of cerebral amyloidosis.

  2026cites this paper
• RIN3 mutations impairing binding of the Alzheimer’s disease–associated protein BIN1 lead to RAB5 hyperactivation and endosomal pathology

  2026cites this paper
• Central integration mechanisms of neurovascular unit dysfunction and novel synergistic therapeutic strategies.

  2025cites this paper
• Research models to study lewy body dementia

  2025cites this paper
• Brain Organoids in Neurodegenerative Disease Modeling: Advances, Applications and Future Perspectives

  2025cites this paper
• Alzheimer’s Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory

  2025cites this paper
• Tau aggregation induces cell death in iPSC-derived neurons

  2025cites this paper
• Neurobiological perturbations in bipolar disorder compared to schizophrenia - evidence from cell cultures and brain organoids.

  2025cites this paper
• Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications

  2025cites this paper
• Chemical Tomography of Cancer Organoids and Cyto‐Proteo‐Genomic Development Stages Through Chemical Communication Signals

  2025cites this paper
• Two- and Three-Dimensional In Vitro Models of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Applications

  2025cites this paper
• Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease

  2025cites this paper
• Research Progress on Neural Cell Culture Systems

  2025influential citation
• Establishment of a Depression Model Using Dexamethasone-treated Three-dimensional Cultured Rat Cortical Cells

  2025cites this paper
• Brain organoids: building higher-order complexity and neural circuitry models

  2025cites this paper
• Cryopreserving 3D cell culture models of Alzheimer’s disease in hydrogel microbeads

  2025influential citation
• A path forward advancing microphysiological systems.

  2025cites this paper
• The Rise and Deceleration of Neuronal Excitability in Aging and Alzheimer's Disease: Mechanisms, Implications, and Therapeutic Targets.

  2025cites this paper
• Current Development of iPSC-Based Modeling in Neurodegenerative Diseases

  2025cites this paper
• HA-PDL Composite Hydrogel with Self-Regulating Elastic Modulus for FRESH 3D Printing of Neural Cell Model

  2025cites this paper
• Modeling neurodegenerative diseases with brain organoids: from development to disease applications

  2025cites this paper
• Deep Profiling of the Aging Proteome Depicts Neuroinflammation, Synaptic Function, and Phosphorylation in an Accelerated Alzheimer's Disease Cell Model

  2025cites this paper
• Inorganic Nanoparticles-based Drug Delivery Systems for Neurodegenerative Diseases Therapy.

  2025cites this paper
• Formaldehyde induces and promotes Alzheimer's disease pathologies in a 3D human neural cell culture model.

  2025cites this paper
• Scalable human neuronal models of tauopathy producing endogenous seed-competent 4R tau

  2025cites this paper
• Human brain organoids: an innovative model for neurological disorder research and therapy

  2025cites this paper
• Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms

  2025cites this paper
• HydroMEA: A 3D Hydrogel Based Microfluidic Device to Study Electrophysiology for Myelinated Nerve-on-Chip

  2025cites this paper
• Hypotonic Swelling Method for the Isolation of Pure Mitochondria From Primary Human Skeletal Myoblasts for Proteomic Studies

  2025cites this paper
• Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons.

  2025cites this paper
• Neuronal Organoid Engineering and Disease-Focused High-Throughput Neuropharmacology: Advances, Limitations, and Translational Strategies.

  2025cites this paper
• One‐Step Drug Screening System Utilizing Electrophysiological Activity in Multiple Brain Organoids

  2025cites this paper
• Development of Patient-Derived Neuroprogenitor Cells (hNPCs), Neurons and Astrocytes to Explore the Etiology of Guam Parkinsonism-Dementia Complex (PDC)

  2025cites this paper
• Relationship between exosomes and cancer: formation, diagnosis, and treatment

  2025cites this paper
• Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome

  2025cites this paper
• NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndrome

  2025cites this paper
• A new protocol for the development of organoids based on molecular mechanisms in the developing newborn rat brain: Prospective applications in the study of Alzheimer's disease.

  2025cites this paper
• Modeling cerebral development in vitro with L-MYC-immortalized human neural stem cell-derived organoids

  2025cites this paper
• Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective

  2025cites this paper
• Formaldehyde induces and promotes Alzheimer’s disease pathologies in a 3D human neural cell culture system

  2025cites this paper
• The potential of carbohydrate supramolecular hydrogels for long-term 3D culture of primary fibroblasts.

  2025cites this paper
• Magnetic Levitational Assembly of Differentiated SH‐SY5Y Cells for Aβ‐Induced 3D Alzheimer's Disease Modeling and Curcumin Screening

  2025cites this paper
• Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine

  2025cites this paper
• Three-dimensional cell culture technologies in the study of Alzheimer’s disease: a narrative review

  2025cites this paper
• Unveiling roles of NGLY1 in cellular homeostasis and related diseases.

  2025cites this paper
• Semiparametric Causal Discovery and Inference with Invalid Instruments

  2025cites this paper
• Development of Low-Cost CNC-Milled PMMA Microfluidic Chips as a Prototype for Organ-on-a-Chip and Neurospheroid Applications

  2025cites this paper
• Neuroinflammation Based Neurodegenerative In Vitro Model of SH-SY5Y Cells—Differential Effects on Oxidative Stress and Insulin Resistance Relevant to Alzheimer’s Pathology

  2025cites this paper
• An optimized method for directed differentiation of hypothalamic neural stem cells in a 3D culture system

  2025cites this paper
• Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery

  2025cites this paper
• Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids: Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery

  2025cites this paper
• HPDL is critical in human cortical development via regulation of mitochondrial functional properties

  2025cites this paper
• Laminin-Functionalized Gelatin Microgels for the Generation of Functional Neurons from Neural Progenitor Cells.

  2025cites this paper
• Human amylin is a potent antimicrobial peptide that exhibits antimicrobial synergism with the amyloid beta protein

  2025cites this paper
• Modeling Alzheimer’s Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling

  2025cites this paper
• A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences.

  2025cites this paper
• Establishment and characterization of Cri Du Chat neuronal stem cells: a novel promising resource to study the syndrome

  2025cites this paper
• Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease

  2025cites this paper
• Transforming surgical planning and procedures through the synergistic use of additive manufacturing, advanced materials and artificial intelligence: challenges and opportunities.

  2025cites this paper
• Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer’s Disease

  2025cites this paper
• Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer's disease.

  2025cites this paper
• Stem cell-based therapeutic strategies for down syndrome and Alzheimer’s disease

  2025cites this paper
• Regulatory role of LncRNA FMR1-AS1 in the pathogenesis of alzheimer’s disease based on bioinformatics and in vitro experimental validation

  2025cites this paper
• Comprehensive protocol for culturing and functionally characterizing primary mixed neural cells from the neonatal rat cortex.

  2025cites this paper
• Curcumin Delivery in Regenerative Medicine for Alzheimer’s Disease

  2025cites this paper
• Prion and "Prion-Like" Detection: From Conventional Methods to Microfluidics or Lab-on-Chip Platforms to Monitor Seeding and Spreading of Misfolded Proteins.

  2025cites this paper
• A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease

  2025cites this paper
• A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis

  2025cites this paper
• Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer’s Disease-Affected Neurons: Contesting the ‘Obvious’

  2025cites this paper
• Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APPSAA knock-in mouse model of Alzheimer’s disease

  2024cites this paper
• TFR1 knockdown alleviates iron overload and mitochondrial dysfunction during neural differentiation of Alzheimer’s disease-derived induced pluripotent stem cells by interacting with GSK3B

  2024cites this paper
• Improvement of Learning and Memory by Chickpeas (Cicer arietinum L.) Sprout Against Streptozotocin and Induced Amnesia in Rats

  2024cites this paper
• Novel Approaches to Studying SLC13A5 Disease

  2024cites this paper
• 3D bioprinting of human neural tissues with functional connectivity.

  2024cites this paper
• Leveraging Biomaterial Platforms to Study Aging-Related Neural and Muscular Degeneration

  2024cites this paper
• Microphysiological systems for human aging research

  2024cites this paper
• Unlocking the Potential of Human-Induced Pluripotent Stem Cells: Cellular Responses and Secretome Profiles in Peptide Hydrogel 3D Culture

  2024cites this paper
• Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease

  2024cites this paper
• Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia

  2024cites this paper
• AI for Neurodegenerative Experimental Models: Advancements and Applications

  2024cites this paper
• Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

  2024cites this paper
• Intracellular Tau Fragment Droplets Serve as Seeds for Tau Fibrils

  2024cites this paper
• Approaches for studying neuroimmune interactions in Alzheimer's disease.

  2024cites this paper
• Assessment of the level of apoptosis in differentiated pseudo-neuronal cells derived from neural stem cells under the influence of various inducers.

  2024cites this paper
• Advancements in brain organoid models for neurodegenerative disease research

  2024cites this paper
• Pros and Cons of Human Brain Organoids to Study Alzheimer’s Disease

  2024cites this paper
• Locus coeruleus tau is linked to successive cortical tau accumulation

  2024cites this paper
• Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids.

  2024cites this paper
• Alzheimer's Disease from Modeling to Mechanism Research.

  2024cites this paper
• Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model.

  2024cites this paper